Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Kefer

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy|April 1, 1995
A phase IA/IB trial of anti-CD3 murine monoclonal antibody plus low-dose continuous-infusion interleukin-2 in advanced cancer patientsJ A Sosman, C Kefer, R I Fisher, et al.
Oncology Nursing Forum|May 25, 1999
Taste changes experienced by patients receiving chemotherapyR S Wickham, M Rehwaldt, C Kefer, et al.
Urology|December 20, 2005
Risk assessment for occult malignancy in the prostate before radical cystectomyJohn C Kefer, Bryan B Voelzke, Robert C Flanigan, et al.
The Journal of Urology|February 22, 2008
Safety and efficacy of flexible ureterorenoscopy and holmium:YAG lithotripsy for intrarenal stones in anticoagulated casesBurak Turna, Robert J Stein, Marc C Smaldone, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 1, 1995
Evidence for eosinophil activation in cancer patients receiving recombinant interleukin-4: effects of interleukin-4 alone and following interleukin-2 administrationJ A Sosman, K Bartemes, K P Offord, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy|April 1, 1995
A phase IA/IB trial of anti-CD3 murine monoclonal antibody plus low-dose continuous-infusion interleukin-2 in advanced cancer patientsJ A Sosman, C Kefer, R I Fisher, et al.
Oncology Nursing Forum|May 25, 1999
Taste changes experienced by patients receiving chemotherapyR S Wickham, M Rehwaldt, C Kefer, et al.
Urology|December 20, 2005
Risk assessment for occult malignancy in the prostate before radical cystectomyJohn C Kefer, Bryan B Voelzke, Robert C Flanigan, et al.
The Journal of Urology|February 22, 2008
Safety and efficacy of flexible ureterorenoscopy and holmium:YAG lithotripsy for intrarenal stones in anticoagulated casesBurak Turna, Robert J Stein, Marc C Smaldone, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 1, 1995
Evidence for eosinophil activation in cancer patients receiving recombinant interleukin-4: effects of interleukin-4 alone and following interleukin-2 administrationJ A Sosman, K Bartemes, K P Offord, et al.
Pageof 2